يعرض 1 - 20 نتائج من 632 نتيجة بحث عن '"An Verrijken"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal

    المؤلفون: Vacca M., Kamzolas I., Harder L. M., Oakley F., Trautwein C., Hatting M., Ross T., Bernardo B., Oldenburger A., Hjuler S. T., Ksiazek I., Linden D., Schuppan D., Rodriguez-Cuenca S., Tonini M. M., Castaneda T. R., Kannt A., Rodrigues C. M. P., Cockell S., Govaere O., Daly A. K., Allison M., Honnens de Lichtenberg K., Kim Y. O., Lindblom A., Oldham S., Andreasson A. -C., Schlerman F., Marioneaux J., Sanyal A., Afonso M. B., Younes R., Amano Y., Friedman S. L., Wang S., Bhattacharya D., Simon E., Paradis V., Burt A., Grypari I. M., Davies S., Driessen A., Yashiro H., Pors S., Worm Andersen M., Feigh M., Yunis C., Bedossa P., Stewart M., Cater H. L., Wells S., Schattenberg J. M., Anstee Q. M., Tiniakos D., Perfield J. W., Petsalaki E., Davidsen P., Vidal-Puig A., Cordell H. J., Day C. P., Wonders K., Missier P., McTeer M., Vale L., Oluboyede Y., Breckons M., Boyle J., Bossuyt P. M., Zafarmand H., Vali Y., Lee J., Nieuwdorp M., Holleboom A. G., Angelakis A., Verheij J., Ratziu V., Clement K., Patino-Navarrete R., Pais R., Surabattula R., Myneni S., Straub B. K., Rodrigues-Cuenca S., Campbell M., Lelliott C. J., Oresic M., Hyotylainen T., McGlinchey A., Mato J. M., Millet O., Dufour J. -F., Berzigotti A., Masoodi M., Lange N. F., Pavlides M., Harrison S., Neubauer S., Cobbold J., Mozes F., Akhtar S., Olodo-Atitebi S., Banerjee R., Shumbayawonda E., Dennis A., Andersson A., Wigley I., Romero-Gomez M., Gomez-Gonzalez E., Ampuero J., Castell J., Gallego-Duran R., Fernandez-Lizaranzu I., Montero-Vallejo R., Karsdal M., Rasmussen D. G. K., Leeming D. J., Sinisi A., Musa K., Sandt E., Bugianesi E., Rosso C., Armandi A., Marra F., Gastaldelli A., Svegliati G., Boursier J., Francque S., Vonghia L., Verrijken A., Dirinck E., Ekstedt M., Kechagias S., Yki-Jarvinen H., Porthan K., Arola J., van Mil S., Papatheodoridis G., Cortez-Pinto H., Silva A. P., Valenti L., Pelusi S., Petta S., Pennisi G., Miele L., Liguori A., Geier A., Rau M., Reissing J., Aithal G. P., Francis S., Palaniyappan N., Bradley C., Hockings P., Schneider M., Newsome P. N., Hubscher S., Wenn D., Magnanensi J., Trylesinski A., Mayo R., Alonso C., Duffin K., Chen Y., Hartman M. L., Miller M., McLeod E. J., Scholch C., Ertle J., Coxson H., Gogain J., Ostroff R., Alexander L., Biegel H., Kjaer M. S., Al-Sari N., Veidal S. S., Ellegaard J., Balp M. -M., Jennings L., Martic M., Loffler J., Applegate D., Torstenson R., Fournier-Poizat C., Llorca A., Kalutkiewicz M., Pepin K., Ehman R., Horan G., Ho G., Tai D., Chng E., Xiao T., Patterson S. D., Billin A., Doward L., Twiss J., Thakker P., Derdak Z., Landgren H., Lackner C., Gouw A., Hytiroglou P., Brass C.

    المساهمون: Vacca M., Kamzolas I., Harder L.M., Oakley F., Trautwein C., Hatting M., Ross T., Bernardo B., Oldenburger A., Hjuler S.T., Ksiazek I., Linden D., Schuppan D., Rodriguez-Cuenca S., Tonini M.M., Castaneda T.R., Kannt A., Rodrigues C.M.P., Cockell S., Govaere O., Daly A.K., Allison M., Honnens de Lichtenberg K., Kim Y.O., Lindblom A., Oldham S., Andreasson A.-C., Schlerman F., Marioneaux J., Sanyal A., Afonso M.B., Younes R., Amano Y., Friedman S.L., Wang S., Bhattacharya D., Simon E., Paradis V., Burt A., Grypari I.M., Davies S., Driessen A., Yashiro H., Pors S., Worm Andersen M., Feigh M., Yunis C., Bedossa P., Stewart M., Cater H.L., Wells S., Schattenberg J.M., Anstee Q.M., Tiniakos D., Perfield J.W., Petsalaki E., Davidsen P., Vidal-Puig A., Cordell H.J., Day C.P., Wonders K., Missier P., McTeer M., Vale L., Oluboyede Y., Breckons M., Boyle J., Bossuyt P.M., Zafarmand H., Vali Y., Lee J., Nieuwdorp M., Holleboom A.G., Angelakis A., Verheij J., Ratziu V., Clement K., Patino-Navarrete R., Pais R., Surabattula R., Myneni S., Straub B.K., Rodrigues-Cuenca S., Campbell M.

    مصطلحات موضوعية: steatosis, MASH, MASLD, murine models

    Relation: info:eu-repo/semantics/altIdentifier/pmid/38867022; volume:6; issue:6; firstpage:1178; lastpage:1196; numberofpages:19; journal:NATURE METABOLISM; https://hdl.handle.net/10447/653999

  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المصدر: van Kleef , L A , Francque , S M , Prieto-Ortiz , J E , Sonneveld , M J , Sanchez-Luque , C B , Prieto-Ortiz , R G , Kwanten , W J , Vonghia , L , Verrijken , A , De Block , C , Gadi , Z , Janssen , H L A , de Knegt , R J & Brouwer , W P 2024 , ' Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction ' , Gastroenterology , vol. 167 , no. ....

    وصف الملف: application/pdf

  14. 14
    Academic Journal

    المساهمون: Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 (RNMCD), Institut Pasteur de Lille, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Institut Européen de Génomique du Diabète - European Genomic Institute for Diabetes - FR 3508 (EGID), Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre National de la Recherche Scientifique (CNRS), University of Antwerp (UA), Institute for Translational Research in Inflammation - U 1286 (INFINITE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), This work was supported by: the Nouvelle Societe Française d’Atherosclerose (NSFA, to LC), the FP7 “RESOLVE” (Grant ID: 305707 to BS, AV, SF, LVG) by FP6 “HEPADIP” (Contract LSHM-CT-2005-018734 to SF, LVG, BS), the European Genomic Institute for Diabetes (EGID, ANR10-LABX-0046 to BS), the Agence Nationale de la Recherche (ANR) PreciNASH (ANR-16-RHUS-0006 to BS), DeCodeNASH (ANR-20-CE14-0034 to JTH), the Fondation pour la Recherche Medicale (EQU202203014650), the Association Française pour l’Etude du Foie (AFEF, to RP), the Contrat Plan Etat-Region Hauts-de-France-Centre Transdisciplinaire de la Recherche sur la Longevite (CPER-CTRL) (to RP, AC and LB), an ERC Starting Grant (Metabo3DC no.101042759) (to JTH) and France Relance (ANR-21-PRRD-0076-01 to RP, BS, CB and CD). LC was supported by a PhD fellowship from Institut Pasteur de Lille and Région Haut de France (France). LB was supported by a PhD fellowship from Centre Hospitalier Universitaire (CHU) de Lille and by the "Health PhD 2020" scolarship of I-Site Universit´e de Lille Nord Europe (ULNE) (France). JTH was supported by an EMBO Long Term Fellowship (ALTF 277-2014). SF received a senior clinical research fellowship from the Research Foundation Flanders (1802154N). The project was also partially funded by the Antwerp University (GOA 2018, ID36572)., ANR-16-RHUS-0006,PreciNASH,PreciNASH(2016), ANR-20-CE14-0034,DeCodeNASH,L'activation métabolique des cellules dendritiques dans la steatopathie métabolique(2020), European Project: 101042759,Horizon Europe,ERC-2021-STG,Metabo3DC(2022), European Project: 305707,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,RESOLVE(2013)

    المصدر: ISSN: 0026-0495.

    Relation: info:eu-repo/grantAgreement//101042759/EU/Understanding Metabolic Activation of Dendritic Cells in Non-Alcoholic Fatty Liver Disease/Metabo3DC; info:eu-repo/grantAgreement/EC/FP7/305707/EU/A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol/RESOLVE

  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal

    المساهمون: University hospital of Zurich Zurich, Universität Zürich Zürich = University of Zurich (UZH), Institute for Molecular Systems Biology ETH Zurich (IMSB), Department of Biology ETH Zürich (D-BIOL), Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology Zürich (ETH Zürich)-Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology Zürich (ETH Zürich), Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 (RNMCD), Institut Pasteur de Lille, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Scientific Center for Optical and Electron Microscopy (ScopeM), Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology Zürich (ETH Zürich), University of Groningen Groningen, ITX-lab unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX-lab), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), St George's, University of London, Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Saint-Joseph de Beyrouth (USJ), University of Copenhagen = Københavns Universitet (UCPH), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), AP-HP. Université Paris Saclay, UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Antwerp University Hospital Edegem (UZA), University of Antwerp (UA), University of Amsterdam Amsterdam = Universiteit van Amsterdam (UvA), Columbia University New York, University Hospital of Würzburg, University College of London London (UCL), 603091, ANR-10-LABX-46, 2015T068, CVON2017-2020, AOM06024, 2014/267, Pfizer: 24052829, European Molecular Biology Organization, EMBO: ALTF277-2014, Seventh Framework Programme, FP7, Sixth Framework Programme, FP6: LSHM-CT-2005-018734, Fondation Maladies Rares, FMR, International Atherosclerosis Society, IAS, British Heart Foundation, BHF, European Commission, EC, European Research Council, ERC: 694717, ANR 16-RHUS-0006, Agence Nationale de la Recherche, ANR: ANR-16-RHUS-0007, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF: 310030-185109, 31003A-160126, Fonds De La Recherche Scientifique - FNRS, FNRS, Fonds Wetenschappelijk Onderzoek, FWO: 1802154 N, PG008/08, RG3008, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO: 184.021.007, Universität Zürich, UZH: FK-20-037, We acknowledge the use of data from BIOS-consortium ( http://wiki.bbmri.nl/wiki/BIOS_bios ) which is funded by BBMRI-NL (NWO project 184.021.007). Flow cytometry was performed with equipment of the flow cytometry facility, University of Zurich., This work was conducted as part of the TransCard project of the seventh Framework Program (FP7) granted by the European Commission, to J. Albert Kuivenhoven, A. Tybjaerg-Hansen, and A. von Eckardstein (number 603091) as well as partially the FP7 RESOLVE project (to J.T. Haas, B. Staels, A. Verhaegen, S. Francque, L. Van Gaal, and A. von Eckardstein) and the European Genomic Institute for Diabetes (EGID, ANR-10-LABX-46 to B. Staels). Additional work by A. von Eckardstein’s team was funded by the Swiss National Science Foundation (31003A-160126, 310030-185109) and the Swiss Systems X program (2014/267 Medical Research and Development (MRD) HDL-X). P. Zanoni received funding awards from the Swiss Atherosclerosis Society (Arbeitsgruppe Lipide und Atherosklerose AGLA and the DACH Society for Prevention of Cardiovascular Diseases). G. Panteloglou received funding from the University of Zurich (Forschungskredit, grant no. FK-20-037). J. Albert Kuivenhoven is an Established Investigator from the Dutch Heart Foundation (2015T068). J. Albert Kuivenhoven was also supported by GeniusII (CVON2017-2020). The Laboratory for Vascular Translational Science (L.V.T.S.) team is supported by Fondation Maladies Rares, Programme Hospitalier de Recherche Clinique (PHRC) (AOM06024), and the national project CHOPIN (CHolesterol Personalized Innovation), granted by the Agence Nationale de la Recherche (ANR-16-RHUS-0007). Y. Abou Khalil is supported by a grant from Ministère de l’Education Nationale et de la Technologie (France). J.T. Haas was supported by an EMBO Long Term Fellowship (ALTF277-2014). B. Staels is a recipient of an ERC Advanced Grant (no. 694717). Both are also supported by PreciNASH (ANR 16-RHUS-0006). Research at the Antwerp University Hospital was supported by the European Union: FP6 (HEPADIP Contract LSHM-CT-2005-018734). S. Francque has a senior clinical research fellowship from the Fund for Scientific Research (FWO) Flanders (1802154 N). S.E. Humphries received grants RG3008 and PG008/08 from the British Heart Foundation, and the support of the UCLH NIHR BRC. S.E. Humphries directs the UK Children’s FH Register which has been supported by a grant from Pfizer (24052829) given by the International Atherosclerosis Society., This work was conducted as part of the TransCard project of the seventh Framework Program (FP7) granted by the European Commission, to J. Albert Kuivenhoven, A. Tybjaerg-Hansen, and A. von Eckardstein (number 603091) as well as partially the FP7 RESOLVE project (to J.T. Haas, B. Staels, A. Verhaegen, S. Francque, L. Van Gaal, and A. von Eckardstein) and the European Genomic Institute for Diabetes (EGID, ANR-10-LABX-46 to B. Staels). Additional work by A. von Eckardstein's team was funded by the Swiss National Science Foundation (31003A-160126, 310030-185109) and the Swiss Systems X program (2014/267 Medical Research and Development (MRD) HDL-X). P. Zanoni received funding awards from the Swiss Atherosclerosis Society (Arbeitsgruppe Lipide und Atherosklerose AGLA and the DACH Society for Prevention of Cardiovascular Diseases). G. Panteloglou received funding from the University of Zurich (Forschungskredit, grant no. FK-20-037). J. Albert Kuivenhoven is an Established Investigator from the Dutch Heart Foundation (2015T068). J. Albert Kuivenhoven was also supported by GeniusII (CVON2017-2020). The Laboratory for Vascular Translational Science (L.V.T.S.) team is supported by Fondation Maladies Rares, Programme Hospitalier de Recherche Clinique (PHRC) (AOM06024), and the national project CHOPIN (CHolesterol Personalized Innovation), granted by the Agence Nationale de la Recherche (ANR-16-RHUS-0007). Y. Abou Khalil is supported by a grant from Minist?re de l'Education Nationale et de la Technologie (France). J.T. Haas was supported by an EMBO Long Term Fellowship (ALTF277-2014). B. Staels is a recipient of an ERC Advanced Grant (no. 694717). Both are also supported by PreciNASH (ANR 16-RHUS-0006). Research at the Antwerp University Hospital was supported by the European Union: FP6 (HEPADIP Contract LSHMCT- 2005-018734). S. Francque has a senior clinical research fellowship from the Fund for Scientific Research (FWO) Flanders (1802154 N). S.E. Humphries received grants RG3008 and PG008/08 from the British Heart Foundation, and the support of the UCLH NIHR BRC. S.E. Humphries directs the UK Children's FH Register which has been supported by a grant from Pfizer (24052829) given by the International Atherosclerosis Society., ANR-16-RHUS-0006,PreciNASH,PreciNASH(2016), ANR-16-RHUS-0007,CHOPIN,CHOPIN(2016)

    المصدر: ISSN: 0009-7330.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34809444; PUBMED: 34809444

  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal